Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling

[1]  S. Punwani,et al.  Automatic quantification of the myocardial extracellular volume by cardiac computed tomography: Synthetic ECV by CCT. , 2017, Journal of cardiovascular computed tomography.

[2]  G. Hindricks,et al.  CMR-Derived Extracellular Volume Fraction as a Marker for Myocardial Fibrosis: The Importance of Coexisting Myocardial Inflammation. , 2017, JACC. Cardiovascular imaging.

[3]  J. Mascherbauer,et al.  Cardiac extracellular matrix is associated with adverse outcome in patients with chronic heart failure , 2017, European journal of heart failure.

[4]  S. Plein,et al.  Synthetic Myocardial Extracellular Volume Fraction. , 2017, JACC. Cardiovascular imaging.

[5]  J. Mascherbauer,et al.  Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study , 2016, Circulation. Cardiovascular imaging.

[6]  Reza Nezafat,et al.  A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance—the T1 Mapping and ECV Standardization in cardiovascular magnetic resonance (T1MES) program , 2016, Journal of Cardiovascular Magnetic Resonance.

[7]  J. Moon,et al.  Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study. , 2015, Radiology.

[8]  M. Quiñones,et al.  Association of Myocardial Extracellular Volume and Clinical Outcome: A Cardiac Magnetic Resonance Study , 2015 .

[9]  G. Korosoglou,et al.  T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. , 2015, European heart journal cardiovascular Imaging.

[10]  S. Piechnik,et al.  T1 mapping and survival in systemic light-chain amyloidosis , 2014, European heart journal.

[11]  B. Schnackenburg,et al.  CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. , 2014, JACC. Cardiovascular imaging.

[12]  Richard B Thompson,et al.  Saturation recovery single‐shot acquisition (SASHA) for myocardial T1 mapping , 2014, Magnetic resonance in medicine.

[13]  M. Robson,et al.  Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents , 2014, Journal of Cardiovascular Magnetic Resonance.

[14]  Richard B. Thompson,et al.  Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. , 2014, Radiology.

[15]  S. K. White,et al.  Native T1 mapping in transthyretin amyloidosis. , 2014, JACC. Cardiovascular imaging.

[16]  Stuart A. Taylor,et al.  Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings. , 2013, Radiology.

[17]  G. Maurer,et al.  Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction , 2013, Circulation. Cardiovascular imaging.

[18]  M. Robson,et al.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.

[19]  M. Robson,et al.  T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. , 2013, JACC. Cardiovascular imaging.

[20]  Andrew S Flett,et al.  Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular Volume , 2013, Circulation. Cardiovascular imaging.

[21]  S. K. White,et al.  Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.

[22]  Reza Razavi,et al.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.

[23]  M. Robson,et al.  Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.

[24]  Andrew S Flett,et al.  Human non-contrast T1 values and correlation with histology in diffuse fibrosis , 2013, Heart.

[25]  S. K. White,et al.  Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI , 2013, Journal of Cardiovascular Magnetic Resonance.

[26]  A. Flett,et al.  Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis: An Equilibrium Contrast Cardiovascular Magnetic Resonance Study , 2013, Circulation. Cardiovascular imaging.

[27]  Andrew S Flett,et al.  Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR , 2012, Journal of Cardiovascular Magnetic Resonance.

[28]  T. Nagasaka,et al.  In vivo measurement of longitudinal relaxation time of human blood by inversion-recovery fast gradient-echo MR imaging at 3T. , 2012, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[29]  Peter Kellman,et al.  Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method , 2012, Journal of Cardiovascular Magnetic Resonance.

[30]  P. Kellman,et al.  Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality , 2012, Circulation.

[31]  Titus Kuehne,et al.  Assessment of Diffuse Myocardial Fibrosis in Rats Using Small-Animal Look-Locker Inversion Recovery T1 Mapping , 2011, Circulation. Cardiovascular imaging.

[32]  Stefan Neubauer,et al.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[33]  M. Hayward,et al.  Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.

[34]  Sandeep N. Gupta,et al.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.

[35]  David M Higgins,et al.  T1 measurement using a short acquisition period for quantitative cardiac applications. , 2005, Medical physics.

[36]  Xavier Golay,et al.  Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla , 2004, Magnetic resonance in medicine.

[37]  Risto A Kauppinen,et al.  Effects of hematocrit and oxygen saturation level on blood spin‐lattice relaxation , 2003, Magnetic resonance in medicine.

[38]  R. Kim,et al.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study , 2003, The Lancet.

[39]  A. Macovski,et al.  Estimating oxygen saturation of blood in vivo with MR imaging at 1.5 T , 1991 .

[40]  M. Bucciolini,et al.  Determination of dependence of spin-lattice relaxation rate in serum upon concentration of added iron by magnetic resonance imaging. , 1990, Clinical physics and physiological measurement : an official journal of the Hospital Physicists' Association, Deutsche Gesellschaft fur Medizinische Physik and the European Federation of Organisations for Medical Physics.

[41]  James C Moon,et al.  Automatic Measurement of the Myocardial Interstitium: Synthetic Extracellular Volume Quantification Without Hematocrit Sampling. , 2016, JACC. Cardiovascular imaging.

[42]  A. Greiser,et al.  T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication. , 2016, JACC. Cardiovascular imaging.

[43]  E. Nagel,et al.  T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. , 2016, JACC. Cardiovascular imaging.

[44]  Michael Jerosch-Herold,et al.  T1 Mapping: Basic Techniques and Clinical Applications. , 2016, JACC. Cardiovascular imaging.

[45]  D. Kaye,et al.  Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. , 2015, European heart journal cardiovascular Imaging.

[46]  Dudley J Pennell,et al.  Cardiovascular magnetic resonance: twenty-first century solutions in cardiology. , 2003, Clinical medicine.

[47]  J. Schulz-Menger,et al.  T1 mapping in patients with acute myocardial infarction. , 2003, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[48]  J L Potter,et al.  NMR relaxation of protons in tissues and other macromolecular water solutions. , 1982, Magnetic resonance imaging.